Convertible visceral fat as a therapeutic target to curb obesity

Nature Reviews Drug Discovery

Volumn 15, Issue 6, 2016, Pages 405-424

  Giordano, Antonio ^a   Frontini, Andrea ^b   Cinti, Saverio ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMFEBUTAMONE PLUS NALTREXONE; AMFEPRAMONE; AMLEXANOX; BELORANIB; CANAGLIFLOZIN; DAPAGLIFLOZIN; DESVENLAFAXINE; EXENDIN 4; FENFLURAMINE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; JANUS KINASE INHIBITOR; LIRAGLUTIDE; LORCASERIN; METFORMIN; METRELEPTIN; MIRABEGRON; PHENTERMINE; PHENTERMINE PLUS TOPIRAMATE; PLACEBO; PRAMLINTIDE; RESVERATROL; RIMONABANT; SETMELANOTIDE; SIBUTRAMINE; TETRAHYDROLIPSTATIN; TOPIRAMATE; UNCOUPLING PROTEIN 1; UNINDEXED DRUG;

ANOREXIA; APHTHOUS STOMATITIS; ASTHMA; ATTENTION DISTURBANCE; BROWN ADIPOCYTE; BROWN ADIPOSE TISSUE; CARDIOVASCULAR DISEASE; CELL TRANSDIFFERENTIATION; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC INFLAMMATION; CONCENTRATION LOSS; CONGENITAL GENERALIZED LIPODYSTROPHY; DEPRESSION; DIET INDUCED OBESITY; DRUG MECHANISM; DRUG MEGADOSE; DRUG REPOSITIONING; DRUG SCREENING; ENERGY BALANCE; ENERGY EXPENDITURE; FATTY LIVER; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPODYSTROPHY; LIVER DISEASE; MEMORY DISORDER; MENTAL DISEASE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OVERACTIVE BLADDER; PARESTHESIA; PHEOCHROMOCYTOMA; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PROADIPOCYTE; REVIEW; RHINITIS; SATIETY; SOMNOLENCE; SUICIDE; THERMOGENESIS; WHITE ADIPOCYTE; WHITE ADIPOSE TISSUE; ADULT; CELL DIFFERENTIATION; CYTOLOGY;

ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ADULT; CELL DIFFERENTIATION; HUMANS; OBESITY; THERMOGENESIS;

EID: 84960369640     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd.2016.31     Document Type: Review

References (241)

1. Lloyd-Jones, D., et al. Heart disease and stroke statistics -2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119, e21-e181 (2009
2. Bornfeldt, K. E., & Tabas, I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 14, 575-585 (2011
3. Hauner, D., & Hauner, H. Metabolic syndrome and breast cancer: is there a link? Breast Care 9, 277-281 (2014
4. Dixon, J. B., le Roux, C. W., Rubino, F., & Zimmet, P. Bariatric surgery for type 2 diabetes. Lancet 379, 2300-2311 (2012
5. Rothwell, N. J., & Stock, M. J. A role for brown adipose tissue in diet-induced thermogenesis. Nature 281, 31-35 (1979
6. Bachman, E. S., et al. βAR signaling required for diet-induced thermogenesis and obesity resistance. Science 297, 843-845 (2002
7. Feldmann, H. M., Golozoubova, V., Cannon, B., & Nedergaard, J. UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell Metab. 9, 203-209 (2009
8. Saito, M., et al. High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes 58, 1526-1531 (2009
9. Virtanen, K. A., et al. Functional brown adipose tissue in healthy adults. N. Engl. J. Med. 360, 1518-1525 (2009
10. van Marken Lichtenbelt, W. D., et al. Cold-activated brown adipose tissue in healthy men. N. Engl. J. Med. 360, 1500-1508 (2009
11. Cypess, A. M., et al. Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med. 360, 1509-1517 (2009
12. Zingaretti, M. C., et al. The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue. FASEB J. 23, 3113-3120 (2009
13. Vijgen, G. H., et al. Brown adipose tissue in morbidly obese subjects. PLoS ONE 6, e17247 (2011
14. Loncar, D. Convertible adipose tissue in mice. Cell Tissue Res. 266, 149-161 (1991
15. Xu, H., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821-1830 (2003
16. Weisberg, S. P., et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808 (2003
17. Strissel, K. J., et al. Adipocyte death, adipose tissue remodeling and obesity complications. Diabetes 56, 2910-2918 (2007
18. Murano, I., et al. Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice. J. Lipid Res. 49, 1562-1568 (2008
19. Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. The metabolic syndrome. Lancet 365, 1415-1428 (2005
20. Cinti, S. The Adipose Organ (Editrice Kurtis, 1999
21. De Jong, J. M., Larsson, O., Cannon, B., & Nedergaard, J. A stringent validation of mouse adipose tissue identity markers. Am. J. Physiol. Endocrinol. Metab. 308, E1085-E1105 (2015
22. Morrison, S. F., Madden, C. J., & Tupone, D. Central neural regulation of brown adipose tissue thermogenesis and energy expenditure. Cell Metab. 19, 741-756 (2014
23. Barbatelli, G., Heinzelmann, M., Ferrara, P., Morroni, M., & Cinti, S. Quantitative evaluations of gap junctions in old rat brown adipose tissue after cold acclimation: a freeze-fracture and ultra-structural study. Tissue Cell 26, 667-676 (1994
24. Cannon, B., & Nedergaard, J. Brown adipose tissue: function and physiological significance. Physiol. Rev. 84, 277-359 (2004
25. Murano, I., Barbatelli, G., Giordano, A., & Cinti, S. Noradrenergic parenchymal nerve fiber branching after cold acclimatisation correlates with brown adipocyte density in mouse adipose organ. J. Anat. 214, 171-178 (2009
26. Vitali, A., et al. The adipose organ of obesity-prone C57BL/6J mice is composed of mixed white and brown adipocytes. J. Lipid Res. 53, 619-629 (2012
27. Barbatelli, G., et al. The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation. Am. J. Physiol. Endocrinol. Metab. 298, E1244-E1253 (2010
28. Rosenwald, M., Perdikari, A., Rulicke, T., & Wolfrum, C. Bi directional interconversion of brite and white adipocytes. Nat. Cell Biol. 15, 659-667 (2013
29. Lee, Y. H., Petkova, A. P., Konkar, A. A., & Granneman, J. G. Cellular origins of cold-induced brown adipocytes in adult mice. FASEB J. 29, 286-299 (2015
30. Sbarbati, A., Morroni, M., Zancanaro, C., & Cinti, S. Rat interscapular brown adipose tissue at different ages: a morphometric study. Int. J. Obes. 15, 581-587 (1991
31. Cinti, S., et al. Immunohistochemical localization of leptin and uncoupling protein in white and brown adipose tissue. Endocrinology 138, 797-804 (1997
32. Himms-Hagen, J. Defective brown adipose tissue thermogenesis in obese mice. Int. J. Obes. 9 (Suppl. 2), 17-24 (1985
33. Young, P., Arch, J. R., & Ashwell, M. Brown adipose tissue in the parametrial fat pad of the mouse. FEBS Lett. 167, 10-14 (1984
34. Cousin, B., et al. Occurrence of brown adipocytes in rat white adipose tissue: molecular and morphological characterization. J. Cell Sci. 103, 931-942 (1992
35. Cao, L., et al. White to brown fat phenotypic switch induced by genetic and environmental activation of a hypothalamic-adipocyte axis. Cell Metab. 14, 324-338 (2011
36. Bostrom, P., et al. A PGC1 α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481, 463-468 (2012
37. De Matteis, R., et al. Exercise as a new physiological stimulus for brown adipose tissue activity. Nutr. Metab. Cardiovasc. Dis. 23, 582-590 (2013
38. Petrovic, N., et al. Chronic peroxisome proliferator-activated receptor γ (PPARγ) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1 containing adipocytes molecularly distinct from classic brown adipocytes. J. Biol. Chem. 285, 7153-7164 (2009
39. Schulz, T. J., et al. Brown-fat paucity due to impaired BMP signalling induces compensatory browning of white fat. Nature 495, 379-383 (2013
40. Schulz, T. J., et al. Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat. Proc. Natl Acad. Sci. USA 108, 143-148 (2011
41. Harms, M., & Seale, P. Brown and beige fat: development, function and therapeutic potential. Nat. Med. 19, 1252-1263 (2013
42. Wu, J., Cohen, P., & Spiegelman, B. M. Adaptive thermogenesis in adipocytes: is beige the new brown? Genes Dev. 27, 234-250 (2013
43. Seale, P., et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature 454, 961-967 (2008
44. Long, J. Z., et al. A smooth muscle-like origin for beige adipocytes. Cell Metab. 19, 810-820 (2014
45. Wu, J., et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150, 366-376 (2012
46. Kazak, L., et al. A creatine-driven substrate cycle enhances energy expenditure and thermogenesis in beige fat. Cell 163, 643-655 (2015
47. Fisher, F. M., et al. FGF21 regulates PGC 1α and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 26, 271-281 (2012
48. Qian, S. W., et al. BMP4 mediated brown fat-like changes in white adipose tissue alter glucose and energy homeostasis. Proc. Natl Acad. Sci. USA 110, E798-E807 (2013
49. Sharp, L. Z., et al. Human BAT possesses molecular signatures that resemble beige/brite cells. PLoS ONE 7, e49452 (2012
50. Shinoda, K., et al. Genetic and functional characterization of clonally derived adult human brown adipocytes. Nat. Med. 21, 389-394 (2015
51. Sacks, H. S., et al. Adult epicardial fat exhibits beige features. J. Clin. Endocrinol. Metab. 98, E1448-E1455 (2013
52. Timmons, J. A., et al. Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages. Proc. Natl Acad. Sci. USA 104, 4401-4406 (2007
53. Sanchez-Gurmaches, J., et al. PTEN loss in the Myf5 lineage redistributes body fat and reveals subsets of white adipocytes that arise from Myf5 precursors. Cell Metab. 16, 348-362 (2012
54. Rosenwald, M., & Wolfrum, C. The origin and definition of brite versus white and classical brown adipocytes. Adipocyte 3, 4-9 (2014
55. Seale, P., et al. Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. J. Clin. Invest. 121, 96-105 (2011
56. Murano, I., et al. Morphology of ferret subcutaneous adipose tissue after 6 month daily supplementation with oral β-carotene. Biochim. Biophys. Acta 1740, 305-312 (2005
57. Himms-Hagen, J., et al. Multilocular fat cells in WAT of CL 316243 treated rats derive directly from white adipocytes. Am. J. Physiol. Cell Physiol. 279, C670-C681 (2000
58. Granneman, J. G., Li, P., Zhu, Z., & Lu, Y. Metabolic and cellular plasticity in white adipose tissue I: effects of β3 adrenergic receptor activation. Am. J. Physiol. Endocrinol. Metab. 289, E608-E616 (2005
59. Walden, T. B., Hansen, I. R., Timmons, J. A., Cannon, B., & Nedergaard, J. Recruited versus nonrecruited molecular signatures of brown, brite, and white adipose tissues. Am. J. Physiol. Endocrinol. Metab. 302, E19-E31 (2012
60. Wang, Q. A., Tao, C., Gupta, R. K., & Scherer, P. E. Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat. Med. 19, 1338-1344 (2013
61. Lee, Y. H., Mottillo, E. P., & Granneman, J. G. Adipose tissue plasticity from WAT to BAT and in between. Biochim. Biophys. Acta 1842, 358-369 (2014
62. Tateishi, K., Okada, Y., Kallin, E. M., & Zhang, Y. Role of Jhdm2a in regulating metabolic gene expression and obesity resistance. Nature 458, 757-761 (2009
63. Mikkelsen, T. S., et al. Comparative epigenomic analysis of murine and human adipogenesis. Cell 143, 156-169 (2010
64. Iyama, K., Ohzono, K., & Usuku, G. Electron microscopical studies on the genesis of white adipocytes: differentiation of immature pericytes into adipocytes in transplanted preadipose tissue. Virchows Archiv. B Cell Pathol. Incl. Mol. Pathol. 31, 143-155 (1979
65. Cinti, S., Cigolini, M., Bosello, O., & Bjorntorp, P. A morphological study of the adipocyte precursor. J. Submicroscop. Cytol. 16, 243-251 (1984
66. Tang, W., et al. White fat progenitor cells reside in the adipose vasculature. Science 322, 583-586 (2008
67. Gupta, R. K., et al. Zfp423 expression identifies committed preadipocytes and localizes to adipose endothelial and perivascular cells. Cell Metab. 15, 230-239 (2012
68. Tran, K. V., et al. The vascular endothelium of the adipose tissue gives rise to both white and brown fat cells. Cell Metab. 15, 222-229 (2012
69. McDonald, M. E., et al. Myocardin-related transcription factor a regulates conversion of progenitors to beige adipocytes. Cell 160, 105-188 (2015
70. Chau, Y. Y., et al. Visceral and subcutaneous fat have different origins and evidence supports a mesothelial source. Nat. Cell Biol. 16, 367-375 (2014
71. Billon, N., et al. The generation of adipocytes by the neural crest. Development 134, 2283-2292 (2007
72. Crossno, J. T., et al. Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells. J. Clin. Invest. 116, 3220-3228 (2006
73. Tomiyama, K., et al. Characterization of transplanted green fluorescent protein+ bone marrow cells into adipose tissue. Stem Cells 26, 330-338 (2008
74. Ryden, M., et al. Transplanted bone marrow-derived cells contribute to human adipogenesis. Cell Metab. 22, 408-417 (2015
75. Berry, R., & Rodeheffer, M. S. Characterization of the adipocyte cellular lineage in vivo. Nat. Cell Bio. 15, 302-308 (2013
76. Rodeheffer, M. S., Birsoy, K., & Friedman, J. M. Identification of white adipocyte progenitor cells in vivo. Cell 135, 240-249 (2008
77. Morrison, S. J., & Spradling, A. C. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 132, 598-611 (2008
78. Blanpain, C., & Simons, B. D. Unravelling stem cell dynamics by lineage tracing. Nat. Rev. Mol. Cell Biol. 14, 489-502 (2013
79. Vague, J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am. J. Clin. Nutr. 4, 20-34 (1956
80. Kissebah, A. H., et al. Relation of body fat distribution to metabolic complications of obesity. J. Clin. Endocrinol. Metab. 54, 254-260 (1982
81. Krotkiewski, M., Bjorntorp, P., Sjostrom, L., & Smith, U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J. Clin. Invest. 72, 1150-1162 (1983
82. Lapidus, L., et al. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. BMJ 289, 1257-1261 (1984
83. Ohlson, L. O., et al. The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow up of the participants in the study of men born in 1913. Diabetes 34, 1055-1058 (1985
84. Peiris, A. N., et al. Relationship of anthropometric measurements of body fat distribution to metabolic profile in premenopausal women. Acta Med. Scand. Suppl. 723, 179-188 (1988
85. Fujioka, S., et al. Treatment of visceral fat obesity. Int. J. Obes. 15 (Suppl. 2), 59-65 (1991
86. Despres, J. P., & Lemieux, I. Abdominal obesity and metabolic syndrome. Nature 444, 881-887 (2006
87. Mittelman, S. D., Van Citters, G. W., Kirkman, E. L., & Bergman, R. N. Extreme insulin resistance of the central adipose depot in vivo. Diabetes 51, 755-761 (2002
88. Mauriege, P., et al. Regional variation in adipose tissue metabolism of severely obese premenopausal women. J. Lipid Res. 36, 672-684 (1995
89. White, U. A., & Tchoukalova, Y. D. Sex dimorphism and depot differences in adipose tissue function. Biochim. Biophys. Acta 1842, 377-392 (2014
90. Smith, U. Abdominal obesity: a marker of ectopic fat accumulation. J. Clin. Invest. 125, 1790-1792 (2015
91. Cote, M., et al. Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J. Clin. Endocrinol. Metab. 90, 1434-1439 (2005
92. Cinti, S., et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 46, 2347-2355 (2005
93. Giordano, A., et al. Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis. J. Lipid Res. 54, 2423-2436 (2013
94. Cotillard, A., et al. Adipocyte size threshold matters: link with risk of type 2 diabetes and improved insulin resistance after gastric bypass. J. Clin. Endocrinol. Metab. 99, E1466-E1470 (2014
95. Trayhurn, P. Hypoxia and adipose tissue function and dysfunction in obesity. Physiol. Rev. 93, 1-21 (2013
96. Guilherme, A., Virbasius, J. V., Puri, V., & Czech, M. P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9, 367-377 (2008
97. Murano, I., et al. Time course of histomorphological changes in adipose tissue upon acute lipoatrophy. Nutr. Metab. Cardiovasc. Dis. 23, 723-731 (2013
98. Harman-Boehm, I., et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J. Clin. Endocrinol. Metab. 92, 2240-2247 (2007
99. Bjorntorp, P. Metabolic abnormalities in visceral obesity. Ann. Med. 24, 3-5 (1992
100. Fernandez-Alfonso, M. S., et al. Mechanisms of perivascular adipose tissue dysfunction in obesity. Int. J. Endocrinol. 2013, 402053 (2013
101. Lastra, G., & Manrique, C. Perivascular adipose tissue, inflammation and insulin resistance: link to vascular dysfunction and cardiovascular disease. Horm. Mol. Biol. Clin. Investig. 22, 19-26 (2015
102. Villacorta, L., & Chang, L. The role of perivascular adipose tissue in vasoconstriction, arterial stiffness, and aneurysm. Horm. Mol. Biol. Clin. Investig. 21, 137-147 (2015
103. Miao, C. Y., & Li, Z. Y. The role of perivascular adipose tissue in vascular smooth muscle cell growth. Br. J. Pharmacol. 165, 643-658 (2012
104. Iantorno, M., et al. Obesity, inflammation and endothelial dysfunction. J. Biol. Regul. Homeost. Agents 28, 169-176 (2014
105. Cypess, A. M., et al. Activation of human brown adipose tissue by a β3 adrenergic receptor agonist. Cell Metab. 21, 33-38 (2015
106. Giordano, A., Frontini, A., Castellucci, M., & Cinti, S. Presence and distribution of cholinergic nerves in rat mediastinal brown adipose tissue. J. Histochem. Cytochem. 52, 923-930 (2004
107. Wei, H., et al. A clinical approach to brown adipose tissue in the para-aortic area of the human thorax. PLoS ONE 10, e0122594 (2015
108. Smith, R. E., & Roberts, J. C. Thermogenesis of brown adipose tissue in cold-acclimated rats. Am. J. Physiol. 206, 143-148 (1964
109. Kuji, I., Imabayashi, E., Minagawa, A., Matsuda, H., & Miyauchi, T. Brown adipose tissue demonstrating intense FDG uptake in a patient with mediastinal pheochromocytoma. Ann. Nucl. Med. 22, 231-235 (2008
110. Cypess, A. M., et al. Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat. Nat. Med. 19, 635-639 (2013
111. van der Lans, A. A., et al. Cold acclimation recruits human brown fat and increases nonshivering thermogenesis. J. Clin. Invest. 123, 3395-3403 (2013
112. Smith, J. D., et al. Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study. J. Clin. Endocrinol. Metab. 97, 1517-1525 (2012
113. Frontini, A., et al. White to brown transdifferentiation of omental adipocytes in patients affected by pheochromocytoma. Biochim. Biophys. Acta 1831, 950-959 (2013
114. Cheng, W., et al. Intense FDG activity in the brown adipose tissue in omental and mesenteric regions in a patient with malignant pheochromocytoma. Clin. Nucl. Med. 37, 514-515 (2012
115. Dong, A., Wang, Y., Lu, J., & Zuo, C. Hypermetabolic mesenteric brown adipose tissue on dual-time point FDG PET/CT in a patient with benign retroperitoneal pheochromocytoma. Clin. Nucl. Med. 39, e229-e232 (2014
116. Connolly, H. M., et al. Valvular heart disease associated with fenfluramine-phentermine. N. Engl. J. Med. 337, 581-588 (1997
117. James, W. P., et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N. Engl. J. Med. 363, 905-917 (2010
118. Despres, J. P., Golay, A., & Sjostrom, L. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N. Engl. J. Med. 353, 2121-2134 (2005
119. Van Gaal, L. F., et al. Effects of the cannabinoid 1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1 year experience from the RIO-Europe study. Lancet 365, 1389-1397 (2005
120. Pi Sunyer, F. X., et al. Effect of rimonabant, a cannabinoid 1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 295, 761-775 (2006
121. Scheen, A. J., et al. Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. Lancet 368, 1660-1672 (2006
122. Ezcurra, M., Reimann, F., Gribble, F. M., & Emery, E. Molecular mechanisms of incretin hormone secretion. Curr. Opin. Pharmacol. 13, 922-927 (2013
123. Astrup, A., et al. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet 374, 1606-1616 (2009
124. Beiroa, D., et al. GLP 1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK. Diabetes 63, 3346-3358 (2014
125. Finan, B., et al. A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents. Nat. Med. 21, 27-36 (2015
126. Rupnick, M. A., et al. Adipose tissue mass can be regulated through the vasculature. Proc. Natl Acad. Sci. USA 99, 10730-10735 (2002
127. Kim, Y. M., et al. Assessment of the anti-obesity effects of the TNP 470 analog, CKD 732. J. Mol. Endocrinol. 38, 455-465 (2007
128. Brakenhielm, E., et al. Angiogenesis inhibitor, TNP 470, prevents diet-induced and genetic obesity in mice. Circul. Res. 94, 1579-1588 (2004
129. Joharapurkar, A. A., Dhanesha, N. A., & Jain, M. R. Inhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesity. Diabetes Metab. Syndr. Obes. 7, 73-84 (2014
130. Kim, D. D., et al. Efficacy and safety of beloranib for weight loss in obese adults: a randomized controlled trial. Diabetes Obes. Metab. 17, 566-572 (2015
131. Ruderman, N. B., et al. AMPK and SIRT1: a long-standing partnership? Am. J. Physiol. Endocrinol. Metab. 298, E751-E760 (2010
132. Picard, F., et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ. Nature 429, 771-776 (2004
133. Qiang, L., et al. Brown remodeling of white adipose tissue by SIRT1 dependent deacetylation of Pparγ. Cell 150, 620-632 (2012
134. De Ligt, M., Timmers, S., & Schrauwen, P. Resveratrol and obesity: can resveratrol relieve metabolic disturbances? Biochim. Biophys. Acta 1852, 1137-1144 (2015
135. Collins, S., Daniel, K. W., Petro, A. E., & Surwit, R. S. Strain-specific response to β3 adrenergic receptor agonist treatment of diet-induced obesity in mice. Endocrinology 138, 405-413 (1997
136. Ghorbani, M., Claus, T. H., & Himms-Hagen, J. Hypertrophy of brown adipocytes in brown and white adipose tissues and reversal of diet-induced obesity in rats treated with a β3 adrenoceptor agonist. Biochem. Pharmacol. 54, 121-131 (1997
137. Ghorbani, M., & Himms-Hagen, J. Appearance of brown adipocytes in white adipose tissue during CL 316,243 induced reversal of obesity and diabetes in Zucker fa/fa rats. Int. J. Obes. Relat. Metab. Disord. 21, 465-475 (1997
138. Berkowitz, D. E., et al. Distribution of β 3 adrenoceptor mRNA in human tissues. Eur. J. Pharmacol. 289, 223-228 (1995
139. van Baak, M. A., et al. Acute effect of L-796568, a novel β 3 adrenergic receptor agonist, on energy expenditure in obese men. Clin. Pharmacol. Ther. 71, 272-279 (2002
140. Larsen, T. M., et al. Effect of a 28 d treatment with L-796568, a novel β(3)-adrenergic receptor agonist, on energy expenditure and body composition in obese men. Am. J. Clin. Nutr. 76, 780-788 (2002
141. Takasu, T., et al. Effect of (R)-2-(2 aminothiazol 4 yl)-4′ {2-[(2 hydroxy 2 phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective β3 adrenoceptor agonist, on bladder function. J. Pharmacol. Exp. Ther. 321, 642-647 (2007
142. Arch, J. R. Challenges in β(3)-adrenoceptor agonist drug development. Ther. Adv. Endocrinol. Metab. 2, 59-64 (2011
143. Karter, Y. Nebivolol: more than a highly selective Beta blocker. Recent Pat. Cardiovasc. Drug Discov. 2, 152-155 (2007
144. Bordicchia, M., et al. Nebivolol induces, via β3 adrenergic receptor, lipolysis, uncoupling protein 1, and reduction of lipid droplet size in human adipocytes. J. Hypertension 32, 389-396 (2014
145. Elbers, J. M., Asscheman, H., Seidell, J. C., Megens, J. A., & Gooren, L. J. Long-term testosterone administration increases visceral fat in female to male transsexuals. J. Clin. Endocrinol. Metab. 82, 2044-2047 (1997
146. Masuzaki, H., et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 294, 2166-2170 (2001
147. Viengchareun, S., Penfornis, P., Zennaro, M. C., & Lombes, M. Mineralocorticoid and glucocorticoid receptors inhibit UCP expression and function in brown adipocytes. Am. J. Physiol. Endocrinol. Metab. 280, E640-E649 (2001
148. Zennaro, M. C., et al. Hibernoma development in transgenic mice identifies brown adipose tissue as a novel target of aldosterone action. J. Clin. Invest. 101, 1254-1260 (1998
149. Caprio, M., et al. Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis. FASEB J. 21, 2185-2194 (2007
150. Ehrhart-Bornstein, M., et al. Human adipocytes secrete mineralocorticoid-releasing factors. Proc. Natl Acad. Sci. USA 100, 14211-14216 (2003
151. Fallo, F., et al. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J. Clin. Endocrinol. Metab. 91, 454-459 (2006
152. Esteves, C. L., et al. Proinflammatory cytokine induction of 11β hydroxysteroid dehydrogenase type 1 (11β HSD1) in human adipocytes is mediated by MEK, C/EBPβ, and NF ?B/RelA. J. Clin. Endocrinol. Metab. 99, E160-E168 (2014
153. Armani, A., et al. Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice. FASEB J. 28, 3745-3757 (2014
154. Parviz, Y., et al. Emerging cardiovascular indications of mineralocorticoid receptor antagonists. Trends Endocrinol. Metab. 26, 201-211 (2015
155. Fukui, Y., Masui, S., Osada, S., Umesono, K., & Motojima, K. A new thiazolidinedione, NC 2100, which is a weak PPAR-γ activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice. Diabetes 49, 759-767 (2000
156. Loft, A., et al. Browning of human adipocytes requires KLF11 and reprogramming of PPARγ superenhancers. Genes Dev. 29, 7-22 (2015
157. Wunderlich, F. T., et al. Hepatic NF B essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis. Proc. Natl Acad. Sci. USA 105, 1297-1302 (2008
158. Chiang, S. H., et al. The protein kinase IKKe regulates energy balance in obese mice. Cell 138, 961-975 (2009
159. Reilly, S. M., et al. A subcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesis. Nat. Commun. 6, 6047 (2015
160. Reilly, S. M., et al. An inhibitor of the protein kinases TBK1 and IKK-e improves obesity-related metabolic dysfunctions in mice. Nat. Med. 19, 313-321 (2013
161. Brestoff, J. R., & Artis, D. Immune regulation of metabolic homeostasis in health and disease. Cell 161, 146-160 (2015
162. De Matteis, R., et al. Immunohistochemical identification of the β(3)-adrenoceptor in intact human adipocytes and ventricular myocardium: effect of obesity and treatment with ephedrine and caffeine. Int. J. Obes. Relat. Metab. Disord. 26, 1442-1450 (2002
163. Seale, P., Kajimura, S., & Spiegelman, B. M. Transcriptional control of brown adipocyte development and physiological function -of mice and men. Genes Dev. 23, 788-797 (2009
164. Mori, M., Nakagami, H., Rodriguez-Araujo, G., Nimura, K., & Kaneda, Y. Essential role for miR 196a in brown adipogenesis of white fat progenitor cells. PLoS Biol. 10, e1001314 (2012
165. Smink, J. J., & Leutz, A. Instruction of mesenchymal cell fate by the transcription factor C/EBPβ. Gene 497, 10-17 (2012
166. Kajimura, S., et al. Initiation of myoblast to brown fat switch by a PRDM16 C/EBP-β transcriptional complex. Nature 460, 1154-1158 (2009
167. Cohen, P., et al. Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch. Cell 156, 304-316 (2014
168. Harms, M. J., et al. Prdm16 is required for the maintenance of brown adipocyte identity and function in adult mice. Cell Metab. 19, 593-604 (2014
169. Rajakumari, S., et al. EBF2 determines and maintains brown adipocyte identity. Cell Metab. 17, 562-574 (2013
170. Trajkovski, M., Ahmed, K., Esau, C. C., & Stoffel, M. MyomiR 133 regulates brown fat differentiation through Prdm16. Nat. Cell Biol. 14, 1330-1335 (2012
171. Ohno, H., Shinoda, K., Spiegelman, B. M., & Kajimura, S. PPARγ agonists induce a white to brown fat conversion through stabilization of PRDM16 protein. Cell Metab. 15, 395-404 (2012
172. Christian, M., et al. RIP140 targeted repression of gene expression in adipocytes. Mol. Cell Biol. 25, 9383-9391 (2005
173. Tsukiyama-Kohara, K., et al. Adipose tissue reduction in mice lacking the translational inhibitor 4E BP1. Nat. Med. 7, 1128-1132 (2001
174. Shinoda, K., et al. Phosphoproteomics identifies CK2 as a negative regulator of beige adipocyte thermogenesis and energy expenditure. Cell Metab. 22, 997-1008 (2015
175. Cantile, M., Procino, A., D'Armiento, M., Cindolo, L., & Cillo, C. HOX gene network is involved in the transcriptional regulation of in vivo human adipogenesis. J. Cell Physiol. 194, 225-236 (2003
176. Trajkovski, M., & Lodish, H. MicroRNA networks regulate development of brown adipocytes. Trends Endocrinol. Metab. 24, 442-450 (2013
177. Swinney, D. C., & Anthony, J. How were new medicines discovered? Nat. Rev. Drug Discov. 10, 507-519 (2011
178. Rix, U., & Superti-Furga, G. Target profiling of small molecules by chemical proteomics. Nat. Chem. Biol. 5, 616-624 (2009
179. Moellering, R. E., & Cravatt, B. F. How chemoproteomics can enable drug discovery and development. Chem. Biol. 19, 11-22 (2012
180. Moisan, A., et al. White to brown metabolic conversion of human adipocytes by JAK inhibition. Nat. Cell Biol. 17, 57-67 (2015
181. Derecka, M., et al. Tyk2 and Stat3 regulate brown adipose tissue differentiation and obesity. Cell Metab. 16, 814-824 (2012
182. Dempersmier, J., et al. Cold-inducible Zfp516 activates UCP1 transcription to promote browning of white fat and development of brown fat. Mol. Cell. 57, 235-246 (2015
183. Wang, T. J., et al. Metabolite profiles and the risk of developing diabetes. Nat. Med. 17, 448-453 (2011
184. Roberts, L. D., et al. β-aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors. Cell Metab. 19, 96-108 (2014
185. Morroni, M., et al. Reversible transdifferentiation of secretory epithelial cells into adipocytes in the mammary gland. Proc. Natl Acad. Sci. USA 101, 16801-16806 (2004
186. Prokesch, A., et al. Molecular aspects of adipoepithelial transdifferentiation in mouse mammary gland. Stem Cells 32, 2756-2766 (2014
187. De Matteis, R., et al. In vivo physiological transdifferentiation of adult adipose cells. Stem Cells 27, 2761-2768 (2009
188. Giordano, A., Smorlesi, A., Frontini, A., Barbatelli, G., & Cinti, S. White, brown and pink adipocytes: the extraordinary plasticity of the adipose organ. Eur. J. Endocrinol. 170, R159-R171 (2014
189. Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175-184 (2007
190. Orr, J. S., et al. Obesity alters adipose tissue macrophage iron content and tissue iron distribution. Diabetes 63, 421-432 (2014
191. Sun, K., Tordjman, J., Clement, K., & Scherer, P. E. Fibrosis and adipose tissue dysfunction. Cell Metab. 18, 470-477 (2013
192. Nguyen, K. D., et al. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 480, 104-108 (2011
193. Qiu, Y., et al. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 157, 1292-1308 (2014
194. Lee, M. W., et al. Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell 160, 74-87 (2015
195. Brestoff, J. R., et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 519, 242-246 (2015
196. Apovian, C. M., et al. Pharmacological management of obesity: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 100, 342-362 (2015
197. Bray, G. A. Medical treatment of obesity: the past, the present and the future. Best Pract. Res. Clin. Gastroenterol. 28, 665-684 (2014
198. Kim, G. W., Lin, J. E., Blomain, E. S., & Waldman, S. A. Antiobesity pharmacotherapy: new drugs and emerging targets. Clin. Pharmacol. Ther. 95, 53-66 (2014
199. Gautron, L., Elmquist, J. K., & Williams, K. W. Neural control of energy balance: translating circuits to therapies. Cell 161, 133-145 (2015
200. Muller, T. D., et al. Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin 4 or FGF2. J. Pept. Sci. 18, 383-393 (2012
201. Chen, K.Y., et al. RM 493, a melanocortin 4 receptor (MC4R) agonist, increases resting energy expenditure in obese individuals. J. Clin. Endocrinol. Metab. 100, 1639-1645 (2015
202. Krishna, R., et al. Potent and selective agonism of the melanocortin receptor 4 with MK 0493 does not induce weight loss in obese human subjects: energy intake predicts lack of weight loss efficacy. Clin. Pharmacol. Ther. 86, 659-666 (2009
203. Opko Health. OPKO announces presentation of data on long-acting oxyntomodulin at diabetes conference. Opko [online], http://investor.opko.com/releasedetail.cfm'releaseid=841731 (2014
204. Day, J. W., et al. A new glucagon and GLP 1 co agonist eliminates obesity in rodents. Nat. Chem. Biol. 5, 749-757 (2009
205. Rajeev, S. P., Cuthbertson, D. J., & Wilding, J. P. Energy balance and metabolic changes with SGLT2 inhibition. Diabetes Obes. Metab. 18, 125-134 (2015
206. Zafgen. Zafgen announces beloranib program update. Zafgen [online], http://ir.zafgen.com/releasedetail. cfm'ReleaseID=937850 (2015
207. US National Library of Medicine. Resveratrol and the metabolic syndrome. ClinicalTrials.gov [online], https://clinicaltrials.gov/ct2/show/NCT01714102'term= resveratrol+AND+obesity& rank=7 (2016
208. Gnad, T., et al. Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptors. Nature 516, 395-399 (2014
209. Emorine, L. J., et al. Molecular characterization of the human β3 adrenergic receptor. Science 245, 1118-1121 (1989
210. Tseng, Y. H., et al. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 454, 1000-1004 (2008
211. Whittle, A. J., et al. BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell 149, 871-885 (2012
212. Hondares, E., et al. Hepatic FGF21 expression is induced at birth via PPARα in response to milk intake and contributes to thermogenic activation of neonatal brown fat. Cell Metab. 11, 206-212 (2010
213. Bordicchia, M., et al. Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J. Clin. Invest. 122, 1022-1036 (2012
214. Lopez, M., et al. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat. Med. 16, 1001-1008 (2010
215. Lehr, L., et al. Control of 4E BP1 expression in mouse brown adipose tissue by the β3 adrenoceptor. FEBS Lett. 576, 179-182 (2004
216. Patwari, P., et al. The arrestin domain-containing 3 protein regulates body mass and energy expenditure. Cell Metab. 14, 671-683 (2011
217. Moreno-Aliaga, M. J., et al. Cardiotrophin 1 is a key regulator of glucose and lipid metabolism. Cell Metab. 14, 242-253 (2011
218. Vegiopoulos, A., et al. Cyclooxygenase 2 controls energy homeostasis in mice by De novo recruitment of brown adipocytes. Science 328, 1158-1161 (2010
219. Madsen, L., et al. UCP1 induction during recruitment of brown adipocytes in white adipose tissue is dependent on cyclooxygenase activity. PLoS ONE 5, e11391 (2010
220. Ohno, H., Shinoda, K., Ohyama, K., Sharp, L. Z., & Kajimura, S. EHMT1 controls brown adipose cell fate and thermogenesis through the PRDM16 complex. Nature 504, 163-167 (2013
221. Cederberg, A., et al. FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell 106, 563-573 (2001
222. Kalaany, N. Y., et al. LXRs regulate the balance between fat storage and oxidation. Cell Metab. 1, 231-244 (2005
223. Rao, R. R., et al. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell. 157, 1279-1291 (2014
224. Chen, Y., et al. miR 155 regulates differentiation of brown and beige adipocytes via a bistable circuit. Nat. Commun. 4, 1769 (2013
225. Sun, L., et al. Mir193b 365 is essential for brown fat differentiation. Nat. Cell Biol. 13, 958-965 (2011
226. Nisoli, E., et al. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 299, 896-899 (2003
227. Puigserver, P., et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829-839 (1998
228. Hondares, E., et al. Peroxisome proliferator-activated receptor α (PPARα) induces PPARγ coactivator 1α (PGC 1α) gene expression and contributes to thermogenic activation of brown fat: involvement of PRDM16. J. Biol. Chem. 286, 43112-43122 (2011
229. Scime, A., et al. Rb and p107 regulate preadipocyte differentiation into white versus brown fat through repression of PGC 1α. Cell Metab. 2, 283-295 (2005
230. Seale, P., et al. Transcriptional control of brown fat determination by PRDM16. Cell Metab. 6, 38-54 (2007
231. Ortega-Molina, A., et al. PTEN positively regulates brown adipose function, energy expenditure, and longevity. Cell Metab. 15, 382-394 (2012
232. Leonardsson, G., et al. Nuclear receptor corepressor RIP140 regulates fat accumulation. Proc. Natl Acad. Sci. USA 101, 8437-8442 (2004
233. Wang, L., et al. The orphan nuclear receptor SHP regulates PGC 1α expression and energy production in brown adipocytes. Cell Metab. 2, 227-238 (2005
234. Yadav, H., et al. Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling. Cell Metab. 14, 67-79 (2011
235. Villanueva, C. J., et al. Adipose subtype-selective recruitment of TLE3 or Prdm16 by PPARγ specifies lipid storage versus thermogenic gene programs. Cell Metab. 17, 423-435 (2013
236. Bartolomucci, A., et al. TLQP 21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity. Proc. Natl Acad. Sci. USA 103, 14584-14589 (2006
237. Pisani, D. F., et al. The K+ channel TASK1 modulates β-adrenergic response in brown adipose tissue through the mineralocorticoid receptor pathway. FASEB J. http://dx.doi.org/10.1096/fj.15 277475 (2015
238. Ma, S., et al. Activation of the cold-sensing TRPM8 channel triggers UCP1 dependent thermogenesis and prevents obesity. J. Mol. Cell Biol. 4, 88-96 (2012
239. Ye, L., et al. TRPV4 is a regulator of adipose oxidative metabolism, inflammation, and energy homeostasis. Cell 151, 96-110 (2012
240. Pan, D., Fujimoto, M., Lopes, A., & Wang, Y. X. Twist 1 is a PPARδ-inducible, negative-feedback regulator of PGC 1α in brown fat metabolism. Cell 137, 73-86 (2009
241. Kiefer, F. W., et al. Retinaldehyde dehydrogenase 1 regulates a thermogenic program in white adipose tissue. Nat. Med. 18, 918-925 (2012